| Evaluation of CD33 as a genetic risk factor for Alzheimer’s disease S Estus, BC Shaw, N Devanney, Y Katsumata, EE Press, DW Fardo Acta neuropathologica 138, 187-199, 2019 | 93 | 2019 |
| Fingolimod reduces neuropathic pain behaviors in a mouse model of multiple sclerosis by a sphingosine-1 phosphate receptor 1-dependent inhibition of central sensitization in … S Doolen, T Iannitti, RR Donahue, BC Shaw, CM Grachen, BK Taylor Pain 159 (2), 224-238, 2018 | 60 | 2018 |
| Targetability of the neurovascular unit in inflammatory diseases of the central nervous system BC Smith, RA Tinkey, BC Shaw, JL Williams Immunological reviews 311 (1), 39-49, 2022 | 31 | 2022 |
| Alzheimer Disease Pathology-Associated Polymorphism in a Complex Variable Number of Tandem Repeat Region Within the MUC6 Gene, Near the AP2A2 Gene Y Katsumata, DW Fardo, AD Bachstetter, SC Artiushin, WX Wang, A Wei, ... Journal of Neuropathology & Experimental Neurology 79 (1), 3-21, 2020 | 23 | 2020 |
| Isolation and identification of leukocyte populations in intracranial blood collected during mechanical thrombectomy BC Shaw, GB Maglinger, T Ujas, C Rupareliya, JF Fraser, S Grupke, ... Journal of Cerebral Blood Flow & Metabolism 42 (2), 280-291, 2022 | 17 | 2022 |
| An alternatively spliced TREM2 isoform lacking the ligand binding domain is expressed in human brain BC Shaw, HC Snider, AK Turner, DJ Zajac, JF Simpson, S Estus Journal of Alzheimer's Disease 87 (4), 1647-1657, 2022 | 16 | 2022 |
| Analysis of genetic variants associated with levels of immune modulating proteins for impact on Alzheimer’s disease risk reveal a potential role for SIGLEC14 BC Shaw, Y Katsumata, JF Simpson, DW Fardo, S Estus Genes 12 (7), 1008, 2021 | 11 | 2021 |
| Exogenous Short Chain Fatty Acid Effects in APP/PS1 Mice DJ Zajac, BC Shaw, DJ Braun, SJ Green, JM Morganti, S Estus Frontiers in Neuroscience 16, 873549, 2022 | 10 | 2022 |
| Immunity impacts cognitive deficits across neurological disorders BC Shaw, VR Anders, RA Tinkey, ML Habean, OD Brock, BJ Frostino, ... Journal of Neurochemistry 168 (10), 3512-3535, 2024 | 8 | 2024 |
| Identification and Quantitation of Novel ABI3 Isoforms Relative to Alzheimer’s Disease Genetics and Neuropathology AK Turner, BC Shaw, JF Simpson, S Estus Genes 13 (9), 1607, 2022 | 6 | 2022 |
| Pseudogene-mediated gene conversion after CRISPR-Cas9 editing demonstrated by partial CD33 conversion with SIGLEC22P B Shaw, S Estus The CRISPR Journal 4 (5), 699-709, 2021 | 5 | 2021 |
| Rapid identification of fermentation spoilage microbes using molecular beacons and a two-step direct DNA amplification protocol B Shaw, C Reekers, W Fenske, D Fugate, M Brock, J Fredericks Journal of the American Society of Brewing Chemists 78 (3), 195-201, 2020 | 2 | 2020 |
| (184) Fingolimod behaves as an agonist at sphingosine-1-phosphate receptor 1 to inhibit pain in an experimental autoimmune encephalomyelitis model of multiple sclerosis B Shaw, S Doolen, T Iannitti, R Donahue, B Taylor The Journal of Pain 18 (4), S22, 2017 | 2 | 2017 |
| A novel PSMB8 isoform associated with multiple sclerosis lesions induces P-body formation BC Shaw, JL Williams Frontiers in Cellular Neuroscience 18, 1379261, 2024 | 1 | 2024 |
| P3‐149: CD33 MOLECULAR GENETICS IN ALZHEIMER'S DISEASE RISK BC Shaw, N Devanney, E Press, Y Katsumata, DW Fardo, S Estus Alzheimer's & Dementia 15, P988-P989, 2019 | 1 | 2019 |
| Nuclear isolation provides clean, ferritin-free, genomic DNA from aged human brain tissue K Nations, JA Brandon, BC Shaw, S Anderson, PT Nelson, MTW Ebbert Alzheimer's Association International Conference, 2022 | | 2022 |
| Immunoregulatory Receptor Genetics, Expression, and Splicing Studies in Alzheimer’s Disease BC Shaw | | 2022 |
